Target intelligence / Profile preview

Gram-negative bacterial inner membrane (IM)

Target
IM
Molecular classification
Phospholipid bilayer, Cellular membrane
01

Overview

The Gram-negative bacterial inner membrane is a symmetric phospholipid bilayer that serves as the primary hydrophobic barrier between the cytoplasm and the periplasmic space. It is composed mainly of phosphatidylethanolamine, phosphatidylglycerol, and cardiolipin, and it houses the machinery for oxidative phosphorylation, active transport, and lipid biosynthesis (Sohlenkamp & Geiger, 2016, FEMS Microbiology Reviews). This membrane is essential for maintaining the proton motive force required for ATP production and flagellar rotation. As a therapeutic target, it is susceptible to membrane-active agents like polymyxins and various antimicrobial peptides which disrupt the bilayer's structural integrity (Trimble et al., 2016, Cold Spring Harbor Perspectives in Medicine). Such disruption leads to the rapid leakage of essential ions and metabolites, resulting in bacterial cell death. While highly effective against multidrug-resistant pathogens, targeting the inner membrane requires high selectivity to avoid damaging host cell membranes. Cross-reactivity with eukaryotic membranes can lead to significant systemic toxicities, such as nephrotoxicity and neurotoxicity (Epand et al., 2016, Journal of Peptide Science). Understanding the unique lipid composition of the bacterial inner membrane is crucial for the development of next-generation antibiotics that can bypass outer membrane defenses.

Other names
Bacterial cytoplasmic membraneBacterial plasma membraneInner membraneBacterial phospholipid bilayer
02

Mechanism of action

Disruption of membrane integrity, induction of pore formation, and dissipation of the proton motive force leading to cytoplasmic leakage and cell death.

03

Biological functions

Selective permeabilityEnergy transductionATP synthesisProtein secretionLipid biosynthesisCell wall precursor synthesisSignal transduction
04

Disease associations

Gram-negative bacterial infectionSepsisPneumoniaUrinary tract infectionMeningitis
05

Safety considerations

NephrotoxicityNeurotoxicityLow therapeutic indexPotential cross-reactivity with mammalian mitochondrial membranesDevelopment of resistance via lipid modification (e.g., mcr genes)
06

Interacting drugs

Polymyxin B

4 more in the full profile.

07

Biomarkers

Membrane potential (Δψ) changesIntracellular potassium leakageATP releasePropidium iodide uptake

Beyond the preview

Go deeper on Gram-negative bacterial inner membrane (IM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gram-negative bacterial inner membrane (IM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call